Viewing SEC Facts Units
Company Name:
Taysha Gene Therapies, Inc.
CIK:
1806310
Start Filing Date:
2022-02-01
End Filing Date:
2022-02-28
ACCN:
0001564590-22-020260
Value:
$ 1,800
Value Error:
$ None
Created By:
Date Filed:
2022-05-16
FY:
2022
Fiscal Period:
Q1
Frame:
CY2022Q1
Type:
us-gaap
Form:
10-Q
Units:
shares